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ABSTRACT: The presence of amyloid plaques composed of
amyloid beta (Aβ) ﬁbrils is a hallmark of Alzheimer’s disease
(AD). The Aβ peptide is present as several length variants with
two common alloforms consisting of 40 and 42 amino acids,
denoted Aβ1−40 and Aβ1−42, respectively. While there have
been numerous reports that structurally characterize ﬁbrils of
Aβ1−40, very little is known about the structure of amyloid
ﬁbrils of Aβ1−42, which are considered the more toxic alloform
involved in AD. We have prepared isotopically 13C/15N labeled
AβM01−42 ﬁbrils in vitro from recombinant protein and
examined their 13C−13C and 13C−15N magic angle spinning
(MAS) NMR spectra. In contrast to several other studies of Aβ
ﬁbrils, we observe spectra with excellent resolution and a single
set of chemical shifts, suggesting the presence of a single ﬁbril morphology. We report the initial structural characterization of
AβM01−42 ﬁbrils utilizing
13C and 15N shift assignments of 38 of the 43 residues, including the backbone and side chains, obtained
through a series of cross-polarization based 2D and 3D 13C−13C, 13C−15N MAS NMR experiments for rigid residues along with
J-based 2D TOBSY experiments for dynamic residues. We ﬁnd that the ﬁrst ∼5 residues are dynamic and most eﬃciently
detected in a J-based TOBSY spectrum. In contrast, residues 16−42 are easily observed in cross-polarization experiments and
most likely form the amyloid core. Calculation of ψ and φ dihedral angles from the chemical shift assignments indicate that 4 β-
strands are present in the ﬁbril’s secondary structure.
■ INTRODUCTION
Protein misfolding and aggregation and the subsequent
formation of amyloid ﬁbrils is established as part of the
pathology of over 40 human diseases,1,2 including Creutzfeldt-
Jakob disease,3,4 Parkinson’s disease,5−10 dialysis related
amyloidosis,11,12 type II diabetes,13,14 Huntington’s disease,15
and Alzheimer’s disease (AD).16−18 Of these, AD is probably
the most prevalent and devastating of the neurodegenerative
diseases. For example, in the US there are currently about 5.2
million AD patients. In addition to the enormous personal
suﬀering, the cost associated with care for these individuals is
$214 billion annually. By 2050 these numbers are projected to
increase to 16 million patients and a cost of $1.2 trillion. There
is therefore an urgent need for new therapeutic or diagnostic
approaches for the treatment of AD and for a fundamental
understanding of the underlying chemical and structural
biology.
One of the hallmarks of AD is the accumulation of
amyloidogenic senile plaques found in Alzheimer’s patients
consisting of ﬁbrils composed of β-amyloid protein (Aβ), a
peptide with 39−43 residues, that is produced from cleavage of
the amyloid precursor protein (APP) by β- and γ-
secretases.19,20 Among the most prevalent alloforms are
peptides with 40 (Aβ1−40) and 42 (Aβ1−42) amino acid residues
with the latter identiﬁed as the more toxic species that
possesses a signiﬁcantly higher aggregation propensity and as a
result nucleates ﬁbril formation.21−23 In addition to AD, the
toxic eﬀects of Aβ are also linked to Down’s syndrome (trisomy
21), a genetic disease leading to intellectual impairment and
diminished physical growth and elevated risk of early on-set
AD, as the gene for Aβ is located on chromosome 21.24 Aβ1−40
aggregates have also been shown to act as prions possessing
transmissibility, with Aβ1−40 prions containing cerebral deposits
possessing Aβ1−40 and Aβ1−42, while Aβ1−42 prions form smaller
amyloid deposits consisting of mostly Aβ1−42.
25−27 Moreover,
Aβ ﬁbrils present reactive surfaces for secondary nucleation and
generation of toxic species from monomers in a ﬁbril-catalyzed
reaction.28−31 Elucidating the structural details of Aβ1−42 ﬁbrils
is therefore an important ﬁrst step toward understanding this
autocatalytic process. In addition, structures can guide the
rational design of diagnostic and therapeutic tools with which
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to diagnose and treat AD, and potentially Down’s syndrome as
well.
Unfortunately, Aβ ﬁbrils are insoluble and do not diﬀract to
high resolution, rendering conventional tools for biological
structure determination such as solution NMR spectroscopy
and X-ray diﬀraction currently incapable of characterizing
samples such as these. Fortunately, magic angle spinning
(MAS) nuclear magnetic resonance (NMR) spectroscopy has
proven to be a powerful technique to elucidate the structural
details of amyloid ﬁbrils on an atomic level, including backbone
conformations, supramolecular organization, and registry of
interstrand arrangements of amyloid ﬁbrils.32 Using this
approach, we have recently determined the high-resolution
structure of amyloid ﬁbrils formed by a small peptide within
transthyretin (TTR105−115) utilizing the combination of cryo-
electron microscopy (cryo-EM) and MAS NMR spectra.33,34
Similar approaches have been used to determine the structure
of Aβ1−40 carrying the Osaka mutation (E22Δ)35,36 and Het-
S.37−39
The initial MAS NMR characterization of an amyloid was an
Aβ fragment consisting of the residues Aβ34−42 and revealed an
antiparallel cross-β structure.40 Subsequently, investigations of
Aβ10−35
41,42 lead to a structural model where the basic subunit
of the ﬁbril consists of two Aβ10−35 monomers that possess
parallel in-register organization and is consistent with the EM,
STEM, and MAS NMR experiments.43 Following these
investigations, a number of studies were devoted to
investigating the structural features of Aβ with diﬀerent ﬁbril
morphologies, and several structural models were pro-
posed.40,43−58 One of the commonalities present in these
structural models is a hairpin conformation consisting of two β-
strands connected by a ﬂexible loop. Tycko and co-workers
have utilized mass per unit length (MPL) measurements of
diﬀerent polymorphs of Aβ prepared from peptide synthesized
protein with speciﬁc amino acids uniformly 13C and 15N labeled
ﬁnding that diﬀerent polymorphs were found to be two or 3-
fold symmetric.55,59 They have also presented data consistent
with a parallel-in-register alignment of the strands in the sheet.
In addition, FS-REDOR69 experiments indicate that a salt
bridge exists between D23 and K28, which may help to stabilize
the loop region within the ﬁbrils.45 More recently, Bertini et al.
characterized AβM01−40 ﬁbrils of recombinant protein with all
residues 13C and 15N labeled, which were prepared under
diﬀerent conditions from those extensively studied by Tycko
and co-workers.49 In that report, the authors observed spectra
consistent with a diﬀerent ﬁbril form, which possessed 2-fold
symmetry. Additionally, Reif and co-workers have also
characterized AβM01−40 prepared from recombinant material
under conditions slightly diﬀerent from Bertini and Tycko and
proposed that an asymmetric dimer is the basic subunit of
AβM01−40 ﬁbrils.
50
Various site-speciﬁc mutations of Aβ1−40 are related to
familial or early onset AD, including the Arctic mutant (E22G),
the Iowa mutant (D23N), and the Osaka mutant (E22Δ). As a
result, signiﬁcant attention has also been devoted to
determining the aggregation mechanism60 and the structure
of the various mutants of Aβ1−40. Tycko and co-workers
reported results indicating that D23N Aβ1−40 ﬁbrils are
polymorphic, with some having parallel interstrand arrange-
ments, while others have antiparallel interstrand arrange-
ments.61,62 Later, they showed that through multiple rounds
of seeding the sample yields a single polymorph.63 Recently, a
high resolution structure of the E22Δ Osaka mutant was
reported by Huber et al.35 and Schuetz et al.36 Following
assignments of the amyloid ﬁbrils the authors utilized a variety
of isotope labeling schemes and recoupling sequences to
generate an excellent high resolution structure with a number
of intra- and intermolecular constraints.35,36 The structure
proposed for the E22Δ mutant is substantially diﬀerent from
other models proposed for Aβ1−40. In particular, while the
Osaka structure has strands that are parallel in register, the
strands are intercalated in a “cinnamon roll” arrangement rather
than forming a simple hairpin proposed in models for wild-type
Aβ1−40
In comparison with the extensive studies of Aβ1−40, little is
known about the structure of Aβ1−42 ﬁbrils,
64−68 which are
established to be more toxic,69 and possess diﬀerent
aggregation properties in comparison with Aβ1−40.
30 Further-
more, genetic mutations that correlate with a predisposition to
AD are known to result in elevated levels of Aβ1−42.
70 To date,
the characterization of Aβ1−42 has largely been limited to H/D
exchange and cryo-EM studies,71 which provide valuable
information about the ﬁbrils, but do not provide atomic level
structural and distance information. Although a sparse number
of MAS NMR studies have been reported on Aβ1−42 ﬁbrils,
71 a
complete structure has yet to be elucidated. Because of the
propensity for Aβ1−42 to aggregate rapidly, it is challenging to
produce homogeneous ﬁbril samples that can yield high quality
MAS NMR spectra with suﬃcient spectral resolution
permitting structural characterization. Additionally, the diﬀer-
ences in behavior of the two alloforms, their distinct
morphologies as observed by cryo-EM and low propensity to
form joint ﬁbrils72 may be indicative of a diﬀerent structure at
short length scale, which propagates into the higher order
morphology with shorter and more tightly twisted AβM01−42
compared to AβM01−40 ﬁbrils,
72 and alternate pathways for
aggregation.30 We have therefore focused our eﬀorts on studies
of AβM01−42 and employed a preparation method that utilized
size exclusion chromatography (SEC) to isolate monomeric
AβM01−42. This is followed by ﬁbrilization yielding samples that
exhibit high quality MAS NMR spectra that allow for a more
complete characterization of the structure of the ﬁbrils.
Furthermore, this approach to sample preparation has recently
been shown to result in reproducible aggregation kinetics.73
Herein, we use MAS NMR along with a new sample
preparation to explore the structure of AβM01−42 ﬁbrils with
the goals of ﬁrst assigning the MAS spectra and, subsequently,
in a future publication reporting the ﬁbril structure.
■ RESULTS AND DISCUSSION
The procedures used in the protein expression and puriﬁcation
are described in the methods section below with details
provided elsewhere.73 Brieﬂy, the peptide was puriﬁed from
inclusion bodies using ion exchange chromatography in batch
format followed by two rounds of size exclusion chromatog-
raphy to isolate pure AβM01−42 monomers. Fibrils formed
spontaneously when this solution was kept at room temper-
ature at pH 8 overnight. An EM of the resultant ﬁbrils, which
have been lyophilized to allow for resuspension in a smaller
volume before packing into the rotor, is shown in Figure 1. The
ﬁbrils have relatively uniform twist distance and thickness, with
an average length of ca. 300 nm, with no amorphous aggregates
present and only one morphology observed. No signiﬁcant
diﬀerence is found relative to fresh ﬁbril samples.29,72 For a
typical β-sheet interpeptide spacing of ca. 0.5 nm, this means
that less than 0.2% of the peptide monomer units are at the
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ﬁbril ends, and the NMR spectra acquired will reliably report
on the core structure of the ﬁbrils. The length of the ﬁbrils
observed in the EM is consistent with the observation that
Aβ1−42 ﬁbrils usually are shorter than Aβ1−40 ﬁbrils.
27,68
We began structurally characterizing the AβM01−42 ﬁbrils by
recording 1D spectra at ω0H/2π = 800 MHz illustrated in
Figure 2, which shows (a) 13C cross-polarization, (b) 13C J-
based INEPT transfers, and (c) 15N cross-polarization. We
found that seeding subsequent samples is successful and we
observe the identical chemical shifts from one sample
preparation to another, producing identical 1D and 2D spectra.
The appearance of signiﬁcant intensity in both the CP- and J-
based experiments indicate that both rigid and dynamic
residues are present within the AβM01−42 ﬁbrils. Similar to the
13C spectra, the 15N 1D spectra display sharp peaks, particularly
within the amide region, as well as the side chains of lysine and
arginine. The breadth of the 15Nδ1/ε2 His side chain lines in our
metal-ion depleted samples is likely due to those residues
undergoing dynamics on the NMR time scale, most likely
proton exchange. In preliminary experiments at 150 K we
observe that the line widths decrease consistent with this
hypothesis. The 15N spectrum is typically a sensitive indicator
of the order within amyloid proteins, and taken in its totality
suggests that our samples are microscopically well ordered, and
typically associated with high quality MAS NMR spectra.
The expected spectral quality was conﬁrmed by the excellent
resolution observed in the 2D RFDR74 (Figure 3A) and ZF-
TEDOR75 (Figure 3B) spectra where line widths of ∼0.5 ppm
are observed for well resolved resonances. Interestingly, and in
contrast to previous reports, only a single set of resonances was
observed, and is well illustrated by the three isoleucine, two
serines, etc. cross peaks present in the RFDR spectrum
indicating that only a single ﬁbril morphology is present within
our sample.
Until recently, most studies of Aβ involved protein prepared
via peptide synthesis and consequently 13C/15N labeling of
individual amino acids. This approach has yielded a good deal
of useful structural data; however, because of the cost of labeled
amino acids it has not been feasible to prepare uniformly
labeled Aβ and therefore to obtain a suﬃciently large number
of structural constraints to calculate an atomic resolution
structure (>5 constraints per residue). In addition, it has
recently been reported that synthetic Aβ is not as neurotoxic as
biosynthetic preparations,69 and the aggregation of synthetic
peptides is slowed.69 Finally, MAS NMR line widths are
broader in synthetic samples. For example, the spectra in prior
publications40,44−46 are signiﬁcantly broader than those
published recently by Bertini et al.49 and Reif, and co-workers.54
These diﬀerences could be possibly due to racemization that
occurs during synthesis and impurities that are diﬃcult to
separate, whereas recombinant expression in Escherichia coli has
excellent ﬁdelity with respect to both sequence homogeneity
and chirality. We also note that that biosynthetic preparations
of PI3-SH3,76 β2-microglobulin,11,12,77 and α-synuclein7,78−94
yield well resolved spectra. In addition, recombinant expression
of protein opens the possibilities of utilizing sparse isotopic
labeling schemes, which can aid in producing high quality MAS
NMR spectra (i.e., 1,3-13C2 -glycerol, 2-
13C1-glycerol,
95−98 and
1,6-13C2- and 2-
13C1-glucose),
99−102 which have recently been
employed for ﬁbrils of Aβ1−40 E22Δ, β2-microglobulin and its
ΔN6 variant.33,79,83
In addition, we recorded 3D spectra (NCOCX, NCACX, and
CONCA)103−107 with representative strip plots shown in
Figure 4 to complete unambiguous assignments of the
backbone and side chain resonances (Table S1). The most
intense signals observed in the NCOCX, CONCA, and
NCACX spectra correspond to residues 25−34 indicating
that these residues are particularly rigid relative to the other
residues. We also recorded a 2D 13C−13C-TOBSY108 to assign
resonances belonging to dynamic portions of the molecule,
(Figure 5). The residues at the N-terminus appear in the J-
based experiments, which has been previously observed in a
variety of ﬁbrils.11,12,49,77
Initially, essentially all of the peaks present in the 2D TOBSY
and the 3D NCOCX and NCACX were assigned, the
exceptions being R5-D7 and Y10-Q15. Since these residues
could be in an intermediate exchange regime, they may be
Figure 1. Negative stain transmission micrograph of AβM01−42 ﬁbrils.
Figure 2. 1D MAS NMR spectra of AβM01−42 recorded at ω0H/2π =
800 MHz at 277 K and ωr/2π = 20 kHz with 83 kHz
1H decoupling
during acquisition. (a) Cross-polarization 1D 13C spectrum recorded
with 512 transients. (b) 13C-INEPT spectrum recorded with 1024
transients. (c) Cross-polarization 1D 15N spectrum recorded with 512
transients.
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observed with longer mixing times, or alternatively lower
temperatures to quench the relevant motions. With this in
mind we recorded an 80 ms mixing DARR (Figure 6) and were
able to assign R5, Y10, E11, and V12. We note that these
resonances are signiﬁcantly weaker than the resonances
observed in the 3D experiments lending support to our
speculation that the resonances absent are in an intermediate
motional regime.
The residues that have been assigned include both the
backbone and side chains with the methods used summarized
as follows: we were able to identify residues M0-F4 through the
J-based 2D TOBSY, and residues S8 and G9 and K16-A42
through the NCOCX, CONCA, and NCACX. Additionally, we
have assigned R5, Y10, E11 and V12 from 2D DARR spectra,
but were unable to identify ﬁve residues, H6, D7, H13, H14
and Q15, that are likely in an intermediate motional regime,
shown schematically in Figure 7.
The chemical shifts of assigned residues were then used as
input to TALOS+109 to estimate the backbone torsion angles
(ψ, φ) (Figure 8), which were in turn utilized to predict the
secondary structures within AβM01−42 ﬁbrils (Table S2). The
dihedral angles predict that four β-strands are present within
each monomer in the secondary structure of the ﬁbrils (Figure
8). The location of the four predicted β-strands is similar but
slightly diﬀerent from other Aβ ﬁbrils that have been reported
in the literature (see Figure 9 and S1), and consistent with the
intensity of the cross-polarization based spectra, in which the
signal intensity is an indicator of rigidity. These β-strands are
expected to be within the core of the ﬁbrils and therefore rigid.
We note that G37 and G38 are potential locations for a loop or
turn but these residues could also be part of a longer β-strand
between M35 and I41. Elucidating further structural details will
determine which of these options is correct. The chemical shifts
of the AβM01−42 ﬁbrils we have studied here do not seem to
correlate with those reported by Bertini et al., who had
characterized AβM01−40 ﬁbrils prepared from recombinant
protein expressed by a similar method to the one we have
employed. This suggests that there may be signiﬁcant structural
diﬀerences between AβM01−42 ﬁbrils and AβM01−40 ﬁbrils, which
may be a result of their diﬀerent hydrophobicities and steric
constraints related to accommodating two extra residues within
the ﬁbril.71 Furthermore, we note that the location of the β-
strands in this work are in slightly diﬀerent locations compared
to many of those reported for Aβ1−40 ﬁbrils. Currently it is
unclear what impact this has on the intra- and intermolecular
structure of AβM01−42. Eﬀorts to address this important question
Figure 3. (a) 1.6 ms mixing RFDR spectrum recorded at 800 MHz, ωr/2π = 20 kHz, VT gas regulated to 277 K with 83 kHz CW
1H decoupling
during evolution, and 83 kHz TPPM 1H decoupling during acquisition. (b) 1.6 ms mixing ZF-TEDOR spectrum recorded at 800 MHz, ωr/2π = 20
kHz, VT gas regulated to 277 K with 83 kHz TPPM during acquisition.
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are ongoing. This suggestion is consistent with the cryo-EM
images reported by Fandrich et al. and Schmidt et al. where the
electron density can be mapped into a long strand and a N-
terminus whose structure was not well resolved.65,110
We also note that aggregation of Aβ monomers has been
found to produce polymorphic ﬁbrils, with the ﬁbrilization
conditions (i.e., pH, temperature, salt concentration, monomer
concentration, etc.) as some of the variables that aﬀects the
polymorphs observed.111 The polymorphism is believed to be
responsible for broad lines observed in many Aβ MAS spectra
and has limited the structural constraints that can be gleaned
from the spectra. Recently, Lu et al. and Pravastu et al. have
provided evidence that the diﬀerences in morphologies may be
linked to disease symptoms by structurally characterizing ﬁbrils
prepared by seeding ﬁbrils with material extracted from the
brains of patients exhibiting varying presentations of the
disease.47,48 This surprising result provides impetus to
characterize the structure of ﬁbrils with many diﬀerent
morphologies that can be prepared under varying ﬁbrilization
conditions.
■ CONCLUSIONS
We have prepared uniformly 13C/15N labeled AβM01−42 ﬁbrils
consisting of a single polymorph and have structurally
characterized them with chemical shift assignments obtained
from MAS NMR spectra. The backbone and side chains
resonances have been assigned for 38 of the 43 residues
through a series of 2D and 3D CP and J-based transfer
experiments. TALOS+ prediction of ψ and φ angles resulting
from the chemical shifts indicate the presence of four β-strands
within the ﬁbril structure.
These results also indicate that the residues within the
protein have signiﬁcantly diﬀerent mobilities. The ﬁrst ﬁve
residues are the most dynamic and are most easily detected in J-
based TOBSY transfers. In contrast residues 16−42 are
relatively rigid, are detected with CP based transfers and likely
form the core of the AβM01−42 ﬁbrils. Connecting those two
sections is a region of intermediate ﬂexibility, where we observe
weak signals in CP-based experiments for R5, S8, G9, Y10, E11,
and V12, with their intensity being inversely correlated with
temperature. In contrast we do not observe signals from either
CP-based and J-based experiments for H6, D7, H13, H14 amd-
Q15. However, preliminary experiments at 150 K indicate that
the His resonances are modulated by H+ exchange. It seems
likely that additional low temperature experiments will permit
observation and assignment of these residues.
Figure 9 shows a comparison of the location of β-strands in
various Aβ ﬁbrils that have been studied with NMR.35,45,49,55
Many show that the residues from 15 to 40/42 are most likely
to possess β-strand character. Although several studies predict
that β-strands can occur in the ﬁrst 15 residues, it has only been
proposed to be true for Aβ40 ﬁbrils.
■ EXPERIMENTAL SECTION
Sample Preparation. The AβM01−42 peptide was expressed and
puriﬁed as previously reported.73 Brieﬂy, AβM01−42 was expressed in 12
L of M9 minimal medium containing 2 g of U−13C glucose and 1 g of
15NH4Cl per liter. Cells were grown at 37 °C, induced at an OD600 =
0.7−1.0 and harvested 5 h later by centrifugation at 6000g for 8 min.
The cells were stored at −20 °C. Upon puriﬁcation, the pellet was
thawed and resuspended in 100 mL buﬀer containing 10 mM Tris, 1
mM EDTA, pH 7.5 (buﬀer A), sonicated for 1.5 min (half horn, max
output, 50% duty cycle, 50 mL at a time) and centrifuged (18000g for
Figure 4. Representative strip plot of NCOCX (green), CONCA
(red), and NCACX (blue) spectra (recorded at 750 and 800 MHz,
respectively). ωr/2π = 12.5 kHz, T = 277 K, τmix(DARR) = 80 ms. A
83 kHz 1H decoupling ﬁeld was applied during acquisition.
Figure 5. 2D 13C−13C-TOBSY recorded at T = 277 K, ω0H/2π = 800
MHz, ωr/2π = 20 kHz, and τmix(TOBSY) = 9.6 ms. A 83 kHz
1H
decoupling ﬁeld was applied during acquisition.
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7 min) to pellet the inclusion bodies. The inclusion bodies were
sonicated two more times (15 s) in 50 mL buﬀer A and pelleted as
above. The inclusion bodies were then dissolved in buﬀer containing
10 mM Tris, 1 mM EDTA, pH 8.5 (buﬀer B) with 8 M urea, diluted
with three volumes of buﬀer B and added to 100 mL DEAE cellulose
resin equilibrated in buﬀer B with 2 M urea added, and puriﬁed via ion
exchange chromatography in batch format, followed by two size
exclusion chromatography steps in 20 mM sodium phosphate, 0.2 mM
EDTA, 0.02% NaN3, pH 8.0, using a 26 × 600 mm Superdex 75
column, which ensured that only monomeric AβM01−42 was present
when ﬁbrilization began. AβM01−42 ﬁbrils were prepared by incubating
10−50 μM (0.05−0.25 mg/mL) solutions of AβM01−42 in 15 mL
Falcon tubes at room temperature overnight, and the formation of
ﬁbrils conﬁrmed by withdrawing a small aliquot for ﬂuorescence
spectroscopy in the presence of thioﬂavin-T (ThT). The ﬁrst ﬁbril
sample was lyophylized, and resuspended in a smaller volume of water
(milli-Q) before packing into the rotor. Aliquots of this ﬁrst ﬁbril
sample were set aside prior to lyophilization and were added as seeds
to subsequent monomer samples, to ensure formation of ﬁbrils of the
same morphology in all tubes. Subsequent samples were always kept
hydrated and we ﬁnd that the chemical shifts are identical to samples
that had been lyophilized. Thus, in the case of AβM1−42 the
lyophilization and rehydrations steps do not signiﬁcantly alter the
ﬁbril structure. 13C−13C and 13C−15N spectra demonstrating this are
shown in Figure S2. Typically, ∼30 mg of hydrated AβM01−42 ﬁbrils
were packed into a 3.2 mm Bruker rotor (Bruker Biospin, Billerica,
MA) using a home-built centrifugal packing tool.
Transmission Electron Microscopy (TEM). TEM images were
acquired using a Philips CM120 BioTWIN electron microscope
equipped with a postcolumn energy ﬁlter (Gatam GIF100) and a
CCD camera. The acceleration voltage was 120 kV. 300 mesh carbon-
coated Formvar grids (Electron Microscopy Sciences, Hatﬁeld, PA)
were placed up-side down on a buﬀer droplet for 2 min, then on a
droplet of the ﬁbril samples for 3 min, followed by a quick (20 s) rinse
Figure 6. 2D 13C−13C MAS spectrum of AβM01−42 ﬁbrils using DARR mixing recorded at a ﬁeld strength corresponding to ω0H/2π = 800 MHz, T =
277 K and ωr/2π = 20 kHz. τmix = 80 ms, with a 83 kHz
1H decoupling ﬁeld applied during acquisition.
Figure 7. Schematic showing the amino acids and side chains with the side chains ﬁlled in. Red circles correspond to assigned 13C’s, blue circles
correspond to assigned 15N’s, and gray circles correspond to resonances that are not observed.
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on a droplet of water (Milli-Q). The grid was then placed on a droplet
of 1.5% uranyl acetate (Merck) for another 3 min to provide the
negative stain.
MAS NMR Spectroscopy. Spectra were acquired on either a
Cambridge Instruments 750 MHz spectrometer operating under
RNMR (courtesy of Dr. David Ruben) or a Bruker 800 MHz
AVANCE III spectrometer equipped with a 3.2 mm triple channel
HCN Bruker probe (Bruker Biospin, Billerica, MA). Spectra were
recorded at ωr/2π = 20 kHz and regulated to ±10 Hz using a Bruker
spinning frequency controller for INEPT-TOBSY,112,113 DARR,114
RFDR,74,115 and ZF-TEDOR,75 and 12.5 kHz ± 10 Hz for 3D
NCOCX, NCACX, CONCA experiments. All experiments were
conducted at 277 K. Spectra recorded at ω0H/2π = 750 MHz (3D
NCOCX and CONCA) were processed, displayed and assigned using
the NMRPipe software package,116 while spectra recorded at ω0H/2π
= 800 MHz (all other) were processed using TopSpin 3.1, and all
spectra were analyzed in Sparky.117
1D 15N spectra were recorded with a CP contact time of 2 ms and
1H/15N ﬁelds of 62.5 kHz, respectively, and a recycle delay of 3 s.
During acquisition, a TPPM118 1H decoupling ﬁeld of 83.3 kHz was
applied. The FID containing 2048 points was averaged over 512
transients. Subsequently, a Gaussian window function with 10 Hz line
broadening was applied and the FID was zero ﬁlled to 8192 points and
Fourier transformed. A 1D refocused carbon insensitive nuclei
enhanced by polarization transfer (INEPT) spectrum was recorded
with an INEPT delay of 1.92 ms (equals a 1JHC coupling of 130 Hz),
and a recycle delay of 2.5 s. The refocusing delay was set to 1.28 ms (=
1/61JHC) selecting all multiplicities (CH, CH2, and CH3). During
acquisition, a WALTZ-16 proton decoupling ﬁeld of 2.5 kHz was
applied. The FID containing 2048 points was averaged over 1024
transients. Subsequently, a Gaussian window function with 10 Hz line
broadening was applied and the FID was zero ﬁlled to 8192 points and
Fourier transformed. 13C and 15N chemical shifts were referenced
using the published shifts of adamantine relative to DSS for 13C
referencing and the IUPAC relative frequency ratios between DSS
(13C) and liquid ammonia (15N).
2D DARR spectra were recorded with a CP contact time of 1.2 ms
and 1H/13C ﬁelds of 62.5 kHz, respectively, and a recycle delay of 2.5
s. For DARR mixing, an 80 ms proton ﬁeld at 20 kHz was applied.
During acquisition, a TPPM 1H decoupling ﬁeld of 83.3 kHz was
applied. The FID matrix containing 2048 × 1024 points was averaged
over 16 transients. Subsequently, a squared sine window function with
a sine bell shift of 3.5 was applied and the FID matrix was zero ﬁlled to
4096 × 2048 points and Fourier transformed.
2D RFDR spectra were recorded with a CP contact time of 1.2 ms
and 1H/13C ﬁelds of 62.5 kHz, respectively, and a recycle delay of 2.5
s. For RFDR mixing, a 1.6 ms 13C RFDR recoupling ﬁeld was applied
using rotor synchronized π pulses at 83 kHz with 100 kHz 1H
decoupling. During acquisition, a TPPM 1H decoupling ﬁeld of 83.3
kHz was applied. The FID matrix containing 2048 × 1024 points was
averaged over 16 transients. Subsequently, a squared sine window
function with a sine bell shift of 3.5 was applied and the FID matrix
was zero ﬁlled to 4096 × 2048 points and Fourier transformed.
Z-ﬁltered transferred echo double resonance (ZF-TEDOR) were
acquired using 3.2 ms mixing with 50 kHz 13C and 15N π-pulses with
83 kHz 1H TPPM decoupling during acquisition and a 3 s recycle
delay. The FID matrix of 1024 × 512 points were averaged for 32
scans.
3D NCOCX used 62.5 kHz and 50 kHz ﬁelds respectively for 1H to
15N transfer (2 ms contact time) with 50 kHz and 62.5 kHz ﬁelds for
15N to 13C magnetization transfer (4 ms contact) with 100 kHz
decoupling during double cross polarization (DCP) transfer and a
carrier frequency of 165 ppm, followed by DARR mixing for 80 ms
with a 12.5 ms 1H DARR ﬁeld and 83 kHz 1H decoupling during
acquisition all with a recycle delay of 3s. The FID acquired had 1024
points, with 240 and 260 points in the second and third dimension,
respectively. Similarly, the CONCA 3D began with cross-polarization
from 1H to 13C with ﬁelds of 71 kHz and 83 kHz respectively, with
100 kHz decoupling during the DCP transfer and 4 ms contact time
during the DCP with 160 and 240 points in the second and third
dimension. The 3D NCACX spectrum was recorded with an initial CP
contact time of 1.2 ms and 1H/13C ﬁelds of 62.5 kHz, respectively, and
a recycle delay of 2.5 s. For DARR mixing, an 80 ms proton ﬁeld at 20
kHz was applied. During acquisition, a TPPM 1H decoupling ﬁeld of
83.3 kHz was applied. The FID matrix containing 2048 × 1024 points
was averaged over 16 transients. Subsequently, a squared sine window
function with a sine bell shift of 3.5 was applied and the FID matrix
was zero ﬁlled to 4096 × 2048 points and Fourier transformed.
Detailed acquisition and processing parameters can be found in
Table S4 and S5, respectively.
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Figure 8. Predicted ψ and φ angles using TALOS. Shaded blue regions
indicate predicted β-strands. On the top of the ﬁgure the black boxes
indicate the location of the beta strands, the solid black line indicate
regions that are in loop or random coil conformations and the dashed
line indicates regions which have not yet been assigned.
Figure 9. Comparison of the locations of predicted β-strands in
various Aβ ﬁbrils. Here, the comparison is limited to NMR chemical
shift data (see Figure S1).
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